These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8299241)

  • 21. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
    Joss N; Rodger RS; McMillan MA; Junor BJ
    Transplantation; 2007 Mar; 83(5):582-7. PubMed ID: 17353778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initiation of ALG pretransplant reduces the incidence of delayed renal allograft function.
    Hong JH; Sumrani N; Cacciarelli TV; Distant D; Sommer BG
    Transplant Proc; 1993 Feb; 25(1 Pt 1):581-2. PubMed ID: 8438423
    [No Abstract]   [Full Text] [Related]  

  • 23. The mechanism behind the effect of ALG on platelets in vivo.
    Henricsson A; Husberg B; Bergentz SE
    Clin Exp Immunol; 1977 Sep; 29(3):515-22. PubMed ID: 589869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thromboembolic complications after renal transplantation: results from the randomized trial of cyclosporine v azathioprine-antilymphocyte globulin.
    Gruber SA; Pescovitz M; Simmons RL; Najarian JS; Ascher NL; Payne WD; Sutherland DE; Elick B; Fryd DS
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1815-6. PubMed ID: 3079041
    [No Abstract]   [Full Text] [Related]  

  • 25. Systemic toxicosis associated with azathioprine administration in domestic cats.
    Beale KM; Altman D; Clemmons RR; Bolon B
    Am J Vet Res; 1992 Jul; 53(7):1236-40. PubMed ID: 1497196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukopenia and azathioprine management in renal homotransplantation.
    Haesslein HC; Pierce JC; Lee HM; Hume DM
    Surgery; 1972 Apr; 71(4):598-604. PubMed ID: 4553659
    [No Abstract]   [Full Text] [Related]  

  • 27. Adverse effect of splenectomy in renal transplantation.
    Rai GS; Wilkinson R; Taylor RM; Uldall PR; Kerr DN
    Clin Nephrol; 1978 May; 9(5):194-9. PubMed ID: 350463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical experience with antilymphocyte globulin (ALG) in renal transplantation.
    Deodhar SD; Konomi K; Nakamoto S; Kuruvila KC
    Transplant Proc; 1971 Mar; 3(1):758-61. PubMed ID: 4937968
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of intensive immunosuppression on the in vitro activity of lymphocytes from multiple sclerosis patients.
    Knight SC; Abbosh J; Lance EM
    Postgrad Med J; 1976; 52(5 Suppl):131-5. PubMed ID: 995783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrence of membranous lupus glomerulonephritis two months after a renal cadaver transplant.
    Lauzurica R; Bonet J; Vaquero M; Torguet P; Serra A; Borrás M; Caralps A
    Transplant Proc; 1992 Feb; 24(1):108-9. PubMed ID: 1539197
    [No Abstract]   [Full Text] [Related]  

  • 31. Factors influencing platelet survival during antilymphocyte globulin treatment.
    Gratama JW; Brand A; Jansen J; Zwaan FE; Valentijn RM; Eernisse JG
    Br J Haematol; 1984 May; 57(1):5-15. PubMed ID: 6722037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunosuppressive therapy in kidney transplantation].
    Flatmark A
    Tidsskr Nor Laegeforen; 1971 Aug; 91(23):1684-6. PubMed ID: 4106716
    [No Abstract]   [Full Text] [Related]  

  • 33. Successful treatment of amegakaryocytic thrombocytopenia with azathioprine.
    Chang H; Tang TC
    Acta Haematol; 2011; 126(3):135-7. PubMed ID: 21701159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large volume diuresis as a mechanism for immediate maximum renal function after transplantation.
    Diethelm AG; Aldrete JS; Sterling WA; Morgan JM
    Surg Gynecol Obstet; 1974 Jun; 138(6):869-74. PubMed ID: 4597109
    [No Abstract]   [Full Text] [Related]  

  • 35. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.
    Connell WR; Kamm MA; Ritchie JK; Lennard-Jones JE
    Gut; 1993 Aug; 34(8):1081-5. PubMed ID: 8174958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignancy after immunosuppressive therapy.
    Mazzei D; Polli EE; Quarto di Palo F
    Boll Ist Sieroter Milan; 1977 Mar; 56(2):197. PubMed ID: 326275
    [No Abstract]   [Full Text] [Related]  

  • 37. Azathioprine for treatment of immune-mediated thrombocytopenia in two horses.
    Humber KA; Beech J; Cudd TA; Palmer JE; Gardner SY; Sommer MM
    J Am Vet Med Assoc; 1991 Sep; 199(5):591-4. PubMed ID: 1787117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased danger of bone marrow damage in simultaneous azathioprine-allopurinol therapy.
    Zazgornik J; Kopsa H; Schmidt P; Pils P; Kuschan K; Deutsch E
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):96-7. PubMed ID: 7228457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombocytopenia complicating infectious hepatitis.
    Laursen HB
    Acta Hepatogastroenterol (Stuttg); 1975 Apr; 22(2):102-5. PubMed ID: 1130162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Malignant T-cell neoplasia during treatment with azathioprine and prednisone after kidney transplantation].
    Olesen LL; Mølby L
    Ugeskr Laeger; 1991 Nov; 153(48):3410-1. PubMed ID: 1957410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.